# Healthbanks Biotech USA Inc – FDA Inspection, May 17, 2011

Source: https://www.keypedia.com/records/fda_inspections/healthbanks-biotech-usa-inc/21a2c494-8878-4f0b-91d8-be213851bbb8
Source feed: FDA_Inspections

> FDA inspection 723566 of Healthbanks Biotech USA Inc, May 17, 2011. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR part 1271. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 723566
- Company Name: Healthbanks Biotech USA Inc
- Inspection Date: 2011-05-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 5

## Related Documents

- FDA Inspection 1131595 - 2020-09-25
- FDA Inspection 1028798 - 2017-09-21
- [FDA Inspection 637139 - 2010-01-15](https://www.keypedia.com/records/fda_inspections/healthbanks-biotech-usa-inc/434adc1f-7a75-4c29-bebd-16eeafcefd57)

Company: https://www.keypedia.com/companies/healthbanks-biotech-usa-inc/a19a0df0-f4e2-4270-9ef8-3b01b5aa990a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d